DXN
Direct-selling company centred on Ganoderma-based health products, earning most revenue overseas across markets such as Latin America and the Middle East.
Buy signals
Open screener ›
09-23
RECLAIM
up-run 1d 1.1%
0.47
09-21
RECLAIM
up-run 1d 1.1%
0.47
Call warrants
No warrants on record for this counter.
Sector strength
Sector Consumer
Half-year strength -38
Sub-sector follows its sector
The season and the half-year strength are the map's own readings for this stock's sector, and they describe a position only. Not a forecast, and not investment advice.
Related reading
The card archive is not connected yet. Once it is, this counter's quarterly and thematic cards appear here.
Peers in the same sector (4)
| Company | Code | Market | Description |
|---|---|---|---|
| AMWAY | 6351 | Main | Malaysian arm of US-based Amway, direct-selling health supplements, nutrition and home and personal care products. |
| BESHOM | 7668 | Main | Formerly Hai-O; direct selling is its largest earnings segment, alongside wholesale and retail of Chinese medicine and wellness products. |
| Citra Nusa Holdings Berhad | 5104 | Main | Citra Nusa Holdings Berhad (formerly CNI Holdings Berhad), listed on Bursa Malaysia's Main Market under code 5104, operates the legacy CNI direct-selling/network-marketing business, distributing wellness, food & beverage, beauty, personal care and household products through a member/distributor network across Malaysia, Singapore and other markets. Direct selling (its Marketing & Trading segment) is the flagship and largest revenue contributor, supported by smaller in-house manufacturing/packaging (Q-Pack, Exclusive Mark), food-ingredient trading (Lotus Supplies) and F&B-outlet operations; FY2024 group revenue was about RM58 million. unverified |
| ZHULIAN | 5131 | Main | Zhulian sells its own jewellery, health and consumer products through a direct-selling network in Malaysia and Southeast Asia. |